Reduced SNAP-25 increases PSD-95 mobility and impairs spine morphogenesis

Cell Death and Differentiation

Volumn 22, Issue 9, 2015, Pages 1425-1436

  Fossati, G ^a,b   Morini, R ^a,b   Corradini, I ^a,c   Antonucci, F ^a,c   Trepte, P ^d   Edry, E ^e   Sharma, V ^e   Papale, A ^f   Pozzi, D ^b   Defilippi, P ^g   Meier, J C ^d,h   Brambilla, R ^f   Turco, E ^g   Rosenblum, K ^e   Wanker, E E ^d   Ziv, N E ⁱ   Menna, E ^b,c   Matteoli, M ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c Istituto di Farmacologia   (Italy)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^e UNIVERSITY OF HAIFA   (Israel)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

ⁱ TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; DLG4 PROTEIN, HUMAN; DLGH4 PROTEIN, MOUSE; GUANYLATE KINASE; MEMBRANE PROTEIN; SIGNAL PEPTIDE; SNAP25 PROTEIN, HUMAN; SNAP25 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DENDRITIC SPINE; DOWN REGULATION; GLUTAMATERGIC SYNAPSE; HIPPOCAMPAL CA1 REGION; IN VIVO STUDY; MORPHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SPINE MORPHOGENESIS; ANIMAL; C57BL MOUSE; GENETIC TRANSFECTION; HEK293 CELL LINE; HIPPOCAMPUS; HUMAN; MALE; METABOLISM; NERVE CELL PLASTICITY; PHYSIOLOGY; SYNAPSE; TRANSGENIC MOUSE;

MUS;

ANIMALS; DENDRITIC SPINES; GUANYLATE KINASES; HEK293 CELLS; HIPPOCAMPUS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MORPHOGENESIS; NEURONAL PLASTICITY; SYNAPSES; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; TRANSFECTION;

EID: 84938869908     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.227     Document Type: Article

References (67)

1. Grant SG. Synaptopathies: diseases of the synaptome. Curr Opin Neurobiol 2012; 22: 522-529.
2. Sheng M, Sabatini BL, Sudhof TC. Synapses and Alzheimer's disease. Cold Spring Harb Perspect Biol 2012; 4: a005777.
3. Gray JA, Roth BL. Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophr Bull 2007; 33: 1100-1119.
4. Yin DM, Chen YJ, Sathyamurthy A, Xiong WC, Mei L. Synaptic dysfunction in schizophrenia. Adv Exp Med Biol 2012; 970: 493-516.
5. Persico AM, Bourgeron T. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci 2006; 29: 349-358.
6. Pizzarelli R, Cherubini E. Alterations of GABAergic signaling in autism spectrum disorders. Neural Plast 2011; 2011: 297153.
7. Washbourne P, Thompson PM, Carta M, Costa ET, Mathews JR, Lopez-Bendito G et al. Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis. Nat Neurosci 2002; 5: 19-26.
8. Sudhof TC, Rothman JE. Membrane fusion: grappling with SNARE and SM proteins. Science 2009; 323: 474-477.
9. Pozzi D, Condliffe S, Bozzi Y, Chikhladze M, Grumelli C, Proux-Gillardeaux V et al. Activitydependent phosphorylation of Ser187 is required for SNAP-25-negative modulation of neuronal voltage-gated calcium channels. Proc Natl Acad Sci USA 2008; 105: 323-328.
10. Condliffe SB, Corradini I, Pozzi D, Verderio C, Matteoli M. Endogenous SNAP-25 regulates native voltage-gated calcium channels in glutamatergic neurons. J Biol Chem 2010; 285: 24968-24976.
11. Feng Y, Crosbie J, Wigg K, Pathare T, Ickowicz A, Schachar R et al. The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder. Mol Psychiatry 2005; 10: 998-1005.
12. Wilson MC. Coloboma mouse mutant as an animal model of hyperkinesis and attention deficit hyperactivity disorder. Neurosci Biobehav Rev 2000; 24: 51-57.
13. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I et al. Genome scan metaanalysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 2003; 73: 34-48.
14. Corradini I, Verderio C, Sala M, Wilson MC, Matteoli M. SNAP-25 in neuropsychiatric disorders. Ann NY Acad Sci 2009; 1152: 93-99.
15. Thompson PM, Egbufoama S, Vawter MP. SNAP-25 reduction in the hippocampus of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 411-417.
16. Thompson PM, Sower AC, Perrone-Bizzozero NI. Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia. Biol Psychiatry 1998; 43: 239-243.
17. Hawi Z, Matthews N, Wagner J, Wallace RH, Butler TJ, Vance A et al. DNA variation in the SNAP25 gene confers risk to ADHD and is associated with reduced expression in prefrontal cortex. PLoS ONE 2013; 8: e60274.
18. Sharma M, Burre J, Bronk P, Zhang Y, Xu W, Sudhof TC. CSPalpha knockout causes neurodegeneration by impairing SNAP-25 function. EMBO J 2012; 31: 829-841.
19. Steffensen SC, Henriksen SJ, Wilson MC. Transgenic rescue of SNAP-25 restores dopamine-modulated synaptic transmission in the coloboma mutant. Brain Res 1999; 847: 186-195.
20. Antonucci F, Corradini I, Morini R, Fossati G, Menna E, Pozzi D et al. Reduced SNAP-25 alters short-term plasticity at developing glutamatergic synapses. EMBO Rep 2013; 14: 645-651.
21. Lau CG, Takayasu Y, Rodenas-Ruano A, Paternain AV, Lerma J, Bennett MV et al. SNAP-25 is a target of protein kinase C phosphorylation critical to NMDA receptor trafficking. J Neurosci 2010; 30: 242-254.
22. Jurado S, Goswami D, Zhang Y, Molina AJ, Sudhof TC, Malenka RC. LTP requires a unique postsynaptic SNARE fusion machinery. Neuron 2013; 77: 542-558.
23. Tomasoni R, Repetto D, Morini R, Elia C, Gardoni F, Di Luca M et al. SNAP-25 regulates spine formation through postsynaptic binding to p140Cap. Nat Commun2013; 4: 2136.
24. Rizzi TS, Beunders G, Rizzu P, Sistermans E, Twisk JW, van Mechelen W et al. Supporting the generalist genes hypothesis for intellectual ability/disability: the case of SNAP25. Genes Brain Behav 2012; 11: 767-771.
25. Corradini I, Donzelli A, Antonucci F, Welzl H, Loos M, Martucci R et al. Epileptiform activity and cognitive deficits in SNAP-25mice are normalized by antiepileptic drugs. Cereb Cortex 2012; 24: 364-376.
26. Kawakami S, Ohmoto M, Itoh S, Yuasa R, Inagaki H, Nishimura E et al. Accumulation of SNAP25 in mouse gustatory and somatosensory cortices in response to food and chemical stimulation. Neuroscience 2012; 218: 326-334.
27. Stern E, Chinnakkaruppan A, David O, Sonenberg N, Rosenblum K. Blocking the eIF2alpha kinase (PKR) enhances positive and negative forms of cortex-dependent taste memory. J Neurosci 2013; 33: 2517-2525.
28. Garner CC, Waites CL, Ziv NE. Synapse development: still looking for the forest, still lost in the trees. Cell Tissue Res 2006; 326: 249-262.
29. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett 1997; 407: 313-319.
30. Lu W, Man H, Ju W, Trimble WS, MacDonald JF, Wang YT. Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron 2001; 29: 243-254.
31. Menna E, Zambetti S, Morini R, Donzelli A, Disanza A, Calvigioni D et al. Eps8 controls dendritic spine density and synaptic plasticity through its actin-capping activity. EMBO J 2013; 32: 1730-1744.
32. El-Husseini AE, Schnell E, Chetkovich DM, Nicoll RA, Bredt DS. PSD-95 involvement in maturation of excitatory synapses. Science 2000; 290: 1364-1368.
33. Sala C, Cambianica I, Rossi F. Molecular mechanisms of dendritic spine development and maintenance. Acta Neurobiol Exp (Wars) 2008; 68: 289-304.
34. Grumelli C, Corradini I, Matteoli M, Verderio C. Intrinsic calcium dynamics control botulinum toxin A susceptibility in distinct neuronal populations. Cell Calcium 2010; 47: 419-424.
35. Nikonenko I, Boda B, Steen S, Knott G, Welker E, Muller D. PSD-95 promotes synaptogenesis and multiinnervated spine formation through nitric oxide signaling. J Cell Biol 2008; 183: 1115-1127.
36. Keller JE, Neale EA. The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A. J Biol Chem 2001; 276: 13476-13482.
37. Bresler T, Ramati Y, Zamorano PL, Zhai R, Garner CC, Ziv NE. The dynamics of SAP90/PSD-95 recruitment to new synaptic junctions. Mol Cell Neurosci 2001; 18: 149-167.
38. Gray NW, Weimer RM, Bureau I, Svoboda K. Rapid redistribution of synaptic PSD-95 in the neocortex in vivo. PLoS Biol 2006; 4: e370.
39. Barrios-Rodiles M, Brown KR, Ozdamar B, Bose R, Liu Z, Donovan RS et al. High-throughput mapping of a dynamic signaling network in mammalian cells. Science 2005; 307: 1621-1625.
40. Petrakis S, Rasko T, Russ J, Friedrich RP, Stroedicke M, Riechers SP et al. Identification of human proteins that modify misfolding and proteotoxicity of pathogenic ataxin-1. PLoS Genet 2012; 8: e1002897.
41. Jaworski J, Kapitein LC, Gouveia SM, Dortland BR, Wulf PS, Grigoriev I et al. Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity. Neuron 2009; 61: 85-100.
42. Zinkel S, Gross A, Yang E. BCL2 family in DNA damage and cell cycle control. Cell Death Diff2006; 13: 1351-1359.
43. Kasai H, Fukuda M, Watanabe S, Hayashi-Takagi A, Noguchi J. Structural dynamics of dendritic spines in memory and cognition. Trends Neurosci 2010; 33: 121-129.
44. Elkobi A, Ehrlich I, Belelovsky K, Barki-Harrington L, Rosenblum K. ERK-dependent PSD-95 induction in the gustatory cortex is necessary for taste learning, but not retrieval. Nat Neurosci 2008; 11: 1149-1151.
45. O'Brien RJ, Lau LF, Huganir RL. Molecular mechanisms of glutamate receptor clustering at excitatory synapses. Curr Opin Neurobiol 1998; 8: 364-369.
46. Lee SH, Sheng M. Development of neuron-neuron synapses. Curr Opin Neurobiol 2000; 10: 125-131.
47. Schnell E, Sizemore M, Karimzadegan S, Chen L, Bredt DS, Nicoll RA. Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number. Proc Natl Acad Sci USA 2002; 99: 13902-13907.
48. Ehrlich I, Malinow R. Postsynaptic density 95 controls AMPA receptor incorporation during long-term potentiation and experience-driven synaptic plasticity. J Neurosci 2004; 24: 916-927.
49. Friedman HV, Bresler T, Garner CC, Ziv NE. Assembly of new individual excitatory synapses: time course and temporal order of synaptic molecule recruitment. Neuron 2000; 27: 57-69.
50. Okabe S, Miwa A, Okado H. Spine formation and correlated assembly of presynaptic and postsynaptic molecules. J Neurosci 2001; 21: 6105-6114.
51. Sabo SL, Gomes RA, McAllister AK. Formation of presynaptic terminals at predefined sites along axons. J Neurosci 2006; 26: 10813-10825.
52. Verhage M, Maia AS, Plomp JJ, Brussaard AB, Heeroma JH, Vermeer H et al. Synaptic assembly of the brain in the absence of neurotransmitter secretion. Science 2000; 287: 864-869.
53. Harms KJ, Craig AM. Synapse composition and organization following chronic activity blockade in cultured hippocampal neurons. J Comp Neurol 2005; 490: 72-84.
54. Bouwman J, Maia AS, Camoletto PG, Posthuma G, Roubos EW, Oorschot VM et al. Quantification of synapse formation and maintenance in vivo in the absence of synaptic release. Neuroscience 2004; 126: 115-126.
55. McAllister AK. Dynamic aspects of CNS synapse formation. Annu Rev Neurosci 2007; 30: 425-450.
56. Bronk P, Deak F, Wilson MC, Liu X, Sudhof TC, Kavalali ET. Differential effects of SNAP-25 deletion on Ca2+dependent and Ca2+independent neurotransmission. J Neurophysiol 2007; 98: 794-806.
57. Selak S, Paternain AV, Aller MI, Pico E, Rivera R, Lerma J. A role for SNAP25 in internalization of kainate receptors and synaptic plasticity. Neuron 2009; 63: 357-371.
58. Verderio C, Pozzi D, Pravettoni E, Inverardi F, Schenk U, Coco S et al. SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization. Neuron 2004; 41: 599-610.
59. Repetto D, Camera P, Melani R, Morello N, Russo I, Calcagno E et al. p140Cap regulates memory and synaptic plasticity through Src-mediated and Citron-N-mediated actin reorganization. J Neurosci 2014; 34: 1542-1553.
60. Penzes P, Cahill ME, Jones KA, VanLeeuwen JE, Woolfrey KM. Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci 2011; 14: 285-293.
61. Washbourne P, Cansino V, Mathews JR, Graham M, Burgoyne RD, Wilson MC. Cysteine residues of SNAP-25 are required for SNARE disassembly and exocytosis, but not for membrane targeting. Biochem J 2001; 357: 625-634.
62. Bartlett WP, Banker GA. An electron microscopic study of the development of axons and dendrites by hippocampal neurons in culture. I. Cells which develop without intercellular contacts. J Neurosci 1984; 4: 1944-1953.
63. Minerbi A, Kahana R, Goldfeld L, Kaufman M, Marom S, Ziv NE. Long-term relationships between synaptic tenacity, synaptic remodeling, and network activity. PLoS Biol 2009; 7: e1000136.
64. Paxinos G, Franklin KB. The Mouse Brain in Stereotaxic Coordinates. Elsevier: San Diego, 2013.
65. Sala C, Piech V, Wilson NR, Passafaro M, Liu G, Sheng M. Regulation of dendritic spine morphology and synaptic function by Shank and Homer. Neuron 2001; 31: 115-130.
66. Frassoni C, Inverardi F, Coco S, Ortino B, Grumelli C, Pozzi D et al. Analysis of SNAP-25 immunoreactivity in hippocampal inhibitory neurons during development in culture and in situ. Neuroscience 2005; 131: 813-823.
67. Di Stefano P, Damiano L, Cabodi S, Aramu S, Tordella L, Praduroux A et al. p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity. EMBO J 2007; 26: 2843-2855.